COLLECTINS AND LUNG DEFENSE
集合素和肺部防御
基本信息
- 批准号:6627298
- 负责人:
- 金额:$ 12.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The present application seeks to determine the effect of viral infection
on surfactant homeostasis and the role of surfactant protein-A (SP-A)
in protecting the lung from viral infection. The lung is continually
exposed to inhaled pathogens, yet, remains remarkably free from
infection. SP-A is an abundant lung selective collectin produced by the
respiratory epithelium and secreted in the airway. In vitro SP-A
enhanced phagocytosis and killing of microbial pathogens. To directly
determine the role of SP-A in vivo, gene targeted mice lacking SP-A (SP-
A-/-) were generated. SP-A (-/-) mice are susceptible to bacterial
infection. The present application tests the hypothesis that viral
infection alters surfactant phospholipid and protein concentrations and
SP-A protects the lung from viral infection in vivo by protecting
respiratory epithelial cells from infection and enhancing phagocytosis
and modulating synthesis of free radicals by alveolar macrophages. To
determine the role of SP-A in lung defense, experiments will determine
if SP-A protects mice in vivo from respiratory syncytial virus (RSV)
infection. To determine viral clearance mechanisms modulated by SP-A,
RSV phagocytosis and generation of oxygen and nitrogen radicals by
alveolar macrophages will be assessed in the presence and absence of SP-
A. This application will determine the role and delineate mechanisms
by which SP-A provides innate immunity to prevent RSV infections. Such
data may be useful in the future in designing treatment and prevention
of viral pneumonia in susceptible patients.
The principle investigator for this proposal has completed a fellowship
in critical care medicine and is currently a Research Instructor in the
Division of Pulmonary Biology, Department of Pediatrics. Throughout her
training, she has demonstrated a continued interest in and ability to
accomplish basic science investigation. The RCA will allow the PI to
continue to develop in a research environment with many successful
independent investigators focused to pulmonary basic science and
clinical research. The experimental design on this proposal includes
challenging but, particularly in this environment, achievable goals that
will provide important knowledge to the understanding of acute lung
injury and host defense of the lung.
本申请试图确定病毒感染对细胞的影响,
表面活性物质稳态和表面活性蛋白-A(SP-A)的作用
保护肺部免受病毒感染肺持续
暴露于吸入的病原体,然而,仍然显着没有从
感染 SP-A是一种丰富的肺选择性聚集素,由肺巨噬细胞产生,
呼吸道上皮细胞和分泌的气道。 体外SP-A
增强的吞噬作用和杀死微生物病原体。 直接
确定SP-A在体内的作用,缺乏SP-A的基因靶向小鼠(SP-A)
A-/-)。 SP-A(-/-)小鼠对细菌易感
感染 本申请测试了病毒性的
感染改变表面活性剂磷脂和蛋白质浓度,
SP-A在体内通过保护肺免受病毒感染,
呼吸道上皮细胞免受感染并增强吞噬作用
以及调节肺泡巨噬细胞的自由基合成。 到
为了确定SP-A在肺防御中的作用,实验将确定
如果SP-A在体内保护小鼠免受呼吸道合胞病毒(RSV)的侵害,
感染 为了确定SP-A调节的病毒清除机制,
RSV吞噬作用和氧和氮自由基的产生
将在存在和不存在SP的情况下评估肺泡巨噬细胞。
A. 此应用程序将确定角色并描述机制
SP-A通过其提供先天免疫以防止RSV感染。 等
这些数据在未来设计治疗和预防措施时可能会很有用。
病毒性肺炎的发病率
该提案的主要研究员已完成研究金
在重症监护医学,目前是一个研究导师在
小儿科肺生物学室。 在她的整个
培训,她表现出持续的兴趣和能力,
完成基础科学研究。 RCA将允许PI
继续在研究环境中发展,
专注于肺部基础科学的独立研究人员,
临床研究 本方案的实验设计包括
具有挑战性,但特别是在这种环境下,
将为了解急性肺提供重要知识
肺的损伤和宿主防御。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANN MARIE LEVINE其他文献
ANN MARIE LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANN MARIE LEVINE', 18)}}的其他基金
SP-A Receptor Regulation in Lung Innate Defense
肺先天防御中 SP-A 受体的调节
- 批准号:
6765152 - 财政年份:2003
- 资助金额:
$ 12.42万 - 项目类别:
SP-A Receptor Regulation in Lung Innate Defense
肺先天防御中 SP-A 受体的调节
- 批准号:
6904594 - 财政年份:2003
- 资助金额:
$ 12.42万 - 项目类别:
SP-A Receptor Regulation in Lung Innate Defense
肺先天防御中 SP-A 受体的调节
- 批准号:
7228589 - 财政年份:2003
- 资助金额:
$ 12.42万 - 项目类别:
SP-A Receptor Regulation in Lung Innate Defense
肺先天防御中 SP-A 受体的调节
- 批准号:
7122068 - 财政年份:2003
- 资助金额:
$ 12.42万 - 项目类别:
SP-A Receptor Regulation in Lung Innate Defense
肺先天防御中 SP-A 受体的调节
- 批准号:
6677946 - 财政年份:2003
- 资助金额:
$ 12.42万 - 项目类别:
相似海外基金
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
- 批准号:
10611521 - 财政年份:2022
- 资助金额:
$ 12.42万 - 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
- 批准号:
10467737 - 财政年份:2022
- 资助金额:
$ 12.42万 - 项目类别:
Basic research on nucleic acids therapeutics for IL-12p40 gene targeting
IL-12p40基因靶向核酸治疗的基础研究
- 批准号:
20K16082 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A new bladder cancer model based on tissue reprogramming and gene targeting
基于组织重编程和基因靶向的新膀胱癌模型
- 批准号:
10084281 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别:
A new bladder cancer model based on tissue reprogramming and gene targeting
基于组织重编程和基因靶向的新膀胱癌模型
- 批准号:
9896122 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别:
Multiplex gene targeting with CRISPR/Cas9 using single guide RNAs
使用单引导 RNA 通过 CRISPR/Cas9 进行多重基因打靶
- 批准号:
540963-2019 - 财政年份:2019
- 资助金额:
$ 12.42万 - 项目类别:
University Undergraduate Student Research Awards
Development of conditional and inducible gene targeting tools in rabbits
兔子条件性和诱导性基因打靶工具的开发
- 批准号:
9317588 - 财政年份:2017
- 资助金额:
$ 12.42万 - 项目类别:
Core B: Transgenic and Gene-Targeting Institutional Facility
核心 B:转基因和基因靶向机构设施
- 批准号:
10215556 - 财政年份:2017
- 资助金额:
$ 12.42万 - 项目类别:
Exploring function of mu opioid receptor splice variants in rat by gene targeting
通过基因打靶探索大鼠μ阿片受体剪接变体的功能
- 批准号:
9312277 - 财政年份:2016
- 资助金额:
$ 12.42万 - 项目类别:
Mechanistic Study and Gene Targeting to Block HIV Assembly by IN-Binding Protein
通过 IN 结合蛋白阻断 HIV 组装的机制研究和基因靶向
- 批准号:
9377499 - 财政年份:2016
- 资助金额:
$ 12.42万 - 项目类别: